Cargando…
SM04755, a small‐molecule inhibitor of the Wnt pathway, as a potential topical treatment for tendinopathy
The Wnt pathway is upregulated in tendinopathy, affecting inflammation and tenocyte differentiation. Given its potential role in tendinopathy, this signaling pathway may be a relevant target for treatment. The current study examined the therapeutic potential of SM04755, a topical, small‐molecule Wnt...
Autores principales: | Deshmukh, Vishal, Seo, Tim, O'Green, Alyssa L., Ibanez, Maureen, Hofilena, Brian, KC, Sunil, Stewart, Joshua, Dellamary, Luis, Chiu, Kevin, Ghias, Abdullah, Barroga, Charlene, Kennedy, Sarah, Tambiah, Jeyanesh, Hood, John, Yazici, Yusuf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451793/ https://www.ncbi.nlm.nih.gov/pubmed/33104243 http://dx.doi.org/10.1002/jor.24898 |
Ejemplares similares
-
Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease
por: Melchior, Benoît, et al.
Publicado: (2019) -
Individual Participant Symptom Responses to Intra-Articular Lorecivivint in Knee Osteoarthritis: Post Hoc Analysis of a Phase 2B Trial
por: Tambiah, Jeyanesh R. S., et al.
Publicado: (2021) -
Lorecivivint, a Novel Intraarticular CDC‐like Kinase 2 and Dual‐Specificity Tyrosine Phosphorylation‐Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial
por: Yazici, Yusuf, et al.
Publicado: (2020) -
Safety, Tolerability, and Pharmacokinetics of Same-Knee Intra-Articular Injection of Corticosteroid and Lorecivivint Within 7 Days: An Open-Label, Randomized, Parallel-Arm Study
por: Fineman, Mark S., et al.
Publicado: (2023) -
Real-World Health Care Resource Utilization and Costs Among US Patients with Knee Osteoarthritis Compared with Controls
por: Bedenbaugh, Angela V, et al.
Publicado: (2021)